array(3) { ["company_details"]=> array(13) { ["name"]=> string(18) "SEQIRUS UK LIMITED" ["slug"]=> string(27) "f592d-gb-seqirus-uk-limited" ["logo"]=> NULL ["description"]=> NULL ["address_street"]=> string(5) "Point" ["address_place"]=> string(10) "MAIDENHEAD" ["address_region"]=> NULL ["founding_date"]=> string(10) "2015-05-29" ["website_domain"]=> string(13) "seqirus.co.uk" ["website_url"]=> string(25) "https://www.seqirus.co.uk" ["industry_codes"]=> array(2) { [0]=> string(54) "Offices of Holding Companies, Not Elsewhere Classified" [1]=> string(43) "Business Services, Not Elsewhere Classified" } ["employee_count"]=> int(227) ["article_count"]=> int(15) } ["articles"]=> array(2) { [0]=> array(7) { ["title_en"]=> string(43) "UKHSA reaches vaccine deal with CSL Seqirus" ["snippet_en"]=> string(78) "Agreement will provide timely boost to pandemic preparedness against influenza" ["url"]=> string(84) "https://www.pharmatimes.com/news/ukhsa_reaches_vaccine_deal_with_csl_seqirus_1501000" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c51b4045-17a0-4e12-b772-269046637f12" ["source"]=> string(15) "pharmatimes.com" ["publication_date"]=> string(10) "2023-09-26" ["categories"]=> array(3) { [0]=> string(21) "Competitive Behaviour" [1]=> string(8) "Epidemic" [2]=> string(15) "Deals & Tenders" } } [1]=> array(7) { ["title_en"]=> string(42) "CSL closes mRNA vaccine deal with Arcturus" ["snippet_en"]=> string(123) "CSL Seqirus has closed the international partnership and licence agreement with Arcturus Therapeutics for sa-mRNA vaccines." ["url"]=> string(72) "https://www.pharmaceutical-technology.com/news/csl-closes-deal-arcturus/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/02087995-5989-40dc-adce-a5c18f0df482" ["source"]=> string(29) "pharmaceutical-technology.com" ["publication_date"]=> string(10) "2022-12-13" ["categories"]=> array(3) { [0]=> string(15) "Market Movement" [1]=> string(15) "Deals & Tenders" [2]=> string(13) "Collaboration" } } } ["category_annotations"]=> array(9) { [0]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(5) } [1]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(2) } [2]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(2) } [3]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(1) } [4]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(1) } [5]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(1) } [6]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(1) } [7]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(1) } [8]=> array(2) { ["name"]=> string(19) "Government Policies" ["count"]=> int(1) } } } f592d-gb-seqirus-uk-limited

SEQIRUS UK LIMITED

Location

Founded

2015-05-29

Website

https://www.seqirus.co.uk

Articles

15 Articles

Category

Offices of Holding Companies, Not Elsewhere Classified

Business Services, Not Elsewhere Classified

Description

Articles

UKHSA reaches vaccine deal with CSL Seqirus

2023-09-26 (pharmatimes.com)

UKHSA reaches vaccine deal with CSL Seqirus

Agreement will provide timely boost to pandemic preparedness against influenza

Read more
CSL closes mRNA vaccine deal with Arcturus

2022-12-13 (pharmaceutical-technology.com)

CSL closes mRNA vaccine deal with Arcturus

CSL Seqirus has closed the international partnership and licence agreement with Arcturus Therapeutics for sa-mRNA vaccines.

Read more

Newsletter subscription